Andy Rawstron, M.D., Ph.D. Leeds Teaching Hospitals NHS Trust (United Kingdom)

NEW ANTIBODIES AND MRD

Identification and validation of potential targets for the diagnosis and therapy of CLL

Update:

No update is available at this time. Please check back soon.